GLAXOCHEM (UK) UNLIMITED

Company number 04299472

Date	Type	Description	View / Download
11 Sep 2019	AA	Full accounts made up to 31 December 2018	(15 pages)
30 Aug 2019	PSC05	Change of details for Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019	(2 pages)
29 Aug 2019	PSC07	Cessation of Glaxosmithkline Sl Lp as a person with significant control on 29 August 2019	(1 page)
28 Aug 2019	CS01	Confirmation statement made on 28 August 2019 with updates	(4 pages)
02 Aug 2019	AP01	Appointment of Mr Charalampos Panagiotidis as a director on 31 July 2019	(2 pages)
07 Jul 2019	CS01	Confirmation statement made on 23 June 2019 with no updates	(3 pages)
07 May 2019	TM01	Termination of appointment of Simon Paul Dingemans as a director on 1 May 2019	(1 page)
31 Jul 2018	CS01	Confirmation statement made on 23 June 2018 with no updates	(3 pages)
10 Jul 2018	AA	Full accounts made up to 31 December 2017	(16 pages)
06 Mar 2018	PSC05	Change of details for Glaxosmithkline Sl Lp as a person with significant control on 23 June 2017	(2 pages)
06 Mar 2018	PSC09	Withdrawal of a person with significant control statement on 6 March 2018	(2 pages)
14 Aug 2017	AA	Full accounts made up to 31 December 2016	(14 pages)
25 Jun 2017	CS01	Confirmation statement made on 23 June 2017 with updates	(5 pages)
18 Oct 2016	CS01	Confirmation statement made on 4 October 2016 with updates	(5 pages)
17 Jun 2016	AA	Full accounts made up to 31 December 2015	(15 pages)
16 Oct 2015	AR01	Annual return made up to 4 October 2015 with full list of shareholders Statement of capital on 2015-10-16 GBP 2,278,880,199	(6 pages)
03 Jun 2015	AA	Full accounts made up to 31 December 2014	(12 pages)
08 Oct 2014	AR01	Annual return made up to 4 October 2014 with full list of shareholders Statement of capital on 2014-10-08 GBP 2,278,880,199	(6 pages)
19 May 2014	AA	Full accounts made up to 31 December 2013	(12 pages)
28 Oct 2013	AR01	Annual return made up to 4 October 2013 with full list of shareholders Statement of capital on 2013-10-28 GBP 2,278,880,199	(6 pages)
25 Oct 2013	CH02	Director's details changed for Glaxo Group Limited on 8 March 2013	(2 pages)
06 Sep 2013	AA	Full accounts made up to 31 December 2012	(10 pages)
23 Oct 2012	AR01	Annual return made up to 4 October 2012 with full list of shareholders	(6 pages)
23 Oct 2012	CH02	Director's details changed for Edinburgh Pharmaceutical Industries Limited on 22 October 2012	(2 pages)
23 Oct 2012	CH04	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 22 October 2012	(2 pages)